You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
WEARABLE PROGRAMMABLE TACTILE SPEECH AID FOR DEAF PEOPLE
SBC: COULTER ASSOCIATES, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
Human Iduronidase (Hurler Syndrome) Expression in Plants
SBC: CROPTECH CORPORATION Topic: N/AThis research will develop transgenic tobacco as a cost effective bioproduction system for thehuman alpha-L-iduronidase (E.C. 3.2.1.76). Iduronidase (IDUA) enzyme activity is deficient in themucopolysaccharidosis I class (Hurler, Hurler-Scheie and Scheie syndromes) of lysosomal storagedisorders. Enzyme replacement using exogenous IDUA has been shown to be effective in cell cultureand animal diseas ...
SBIR Phase II 1995 Department of Health and Human Services -
Human Iduronidase Hurler syndrome expression in plant
SBC: CROPTECH CORPORATION Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
RECOMBINANT MIS CANCER THERAPEUTIC PRODUCED IN PLANTS
SBC: CROPTECH CORPORATION Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Bioadhesive for Surgery and Wound Repair
SBC: CRYOLIFE, INC. Topic: N/AWe will develop a strong, safe, easy-to-use, biocompatible, and degradable bioadhesive for surgicalrequiring tissue sealing and closure. This bioadhesive will have the potential to streamline commonwell as provide new technology in areas such as organ hemostasis. The following specific aims will agoal: 1) optimize the formulation of the bioadhesive and develop a delivery device; 2) evaluate thetox ...
SBIR Phase I 1995 Department of Health and Human Services -
Xenogeneic Arterial Bypass Graft
SBC: CRYOLIFE, INC. Topic: N/AAlthough the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatofeasibility study in canine subjects to determine whether an immunologically modified xenogeneic vesendothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend tot ...
SBIR Phase I 1995 Department of Health and Human Services -
Fascia Lata Xenograft for ACL Replacement
SBC: CRYOLIFE, INC. Topic: N/AAutologous patellar tendon grafts are the current gold standard for replacement of irreparable anteligaments. Allogeneic tissue grafts are the only accepted alternative to autologous grafts and theysupply. We will develop a non-immunogenic bovine fascia lata as a graft material for anterior cruciagrafts will be rendered non-immunogenic by in vitro processing. The resulting collagen tissue matrixbi ...
SBIR Phase I 1995 Department of Health and Human Services -
ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION
SBC: CRYOLIFE, INC. Topic: N/AN/A
SBIR Phase II 1997 Department of Health and Human Services -
ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION
SBC: CRYOLIFE, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
CRYOPRESERVED ARTERIES AS ALLOGRAFT VASCULAR CONDUIT
SBC: CRYOLIFE, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services
